The Potential Revolution of Cancer Treatment with CRISPR Technology

Immuno-oncology (IO) and targeted therapies, such as small molecule inhibitors, have changed the landscape of cancer treatment and prognosis; however, durable responses have been difficult to achieve due to tumor heterogeneity, development of drug resistance, and adverse effects that limit dosing an...

Full description

Bibliographic Details
Main Authors: Dimitrios Stefanoudakis, Nikhita Kathuria-Prakash, Alexander W. Sun, Melissa Abel, Claire E. Drolen, Camille Ashbaugh, Shiliang Zhang, Gavin Hui, Yeganeh A. Tabatabaei, Yuliya Zektser, Lidia P. Lopez, Allan Pantuck, Alexandra Drakaki
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/6/1813